These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21498513)

  • 21. Impact of the Hereditary P301L Mutation on the Correlated Conformational Dynamics of Human Tau Protein Revealed by the Paramagnetic Relaxation Enhancement NMR Experiments.
    Kawasaki R; Tate SI
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation.
    Jeganathan S; Hascher A; Chinnathambi S; Biernat J; Mandelkow EM; Mandelkow E
    J Biol Chem; 2008 Nov; 283(46):32066-76. PubMed ID: 18725412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FTD-tau S320F mutation stabilizes local structure and allosterically promotes amyloid motif-dependent aggregation.
    Chen D; Bali S; Singh R; Wosztyl A; Mullapudi V; Vaquer-Alicea J; Jayan P; Melhem S; Seelaar H; van Swieten JC; Diamond MI; Joachimiak LA
    Nat Commun; 2023 Mar; 14(1):1625. PubMed ID: 36959205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mercury(II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule-binding domain: Coordination and conformational transition.
    Yang DJ; Shi S; Zheng LF; Yao TM; Ji LN
    Biopolymers; 2010 Dec; 93(12):1100-7. PubMed ID: 20665688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DnaJC7 binds natively folded structural elements in tau to inhibit amyloid formation.
    Hou Z; Wydorski PM; Perez VA; Mendoza-Oliva A; Ryder BD; Mirbaha H; Kashmer O; Joachimiak LA
    Nat Commun; 2021 Sep; 12(1):5338. PubMed ID: 34504072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of the ΔK280 mutation and N- or C-terminal extensions on the structure, dynamics, and fibril morphology of the tau R2 repeat.
    Raz Y; Adler J; Vogel A; Scheidt HA; Häupl T; Abel B; Huster D; Miller Y
    Phys Chem Chem Phys; 2014 May; 16(17):7710-7. PubMed ID: 24448233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine.
    Nadimidla K; Ismail T; Kanapathipillai M
    Biopolymers; 2017 Sep; 107(9):. PubMed ID: 28456996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can any "non-specific charge modification within microtubule binding domains of Tau" be a prerequisite of the protein amyloid aggregation? An in vitro study on the 1N4R isoform.
    Jangholi A; Ashrafi-Kooshk MR; Arab SS; Karima S; Poorebrahim M; Ghadami SA; Moosavi-Movahedi AA; Khodarahmi R
    Int J Biol Macromol; 2018 Apr; 109():188-204. PubMed ID: 29248553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau.
    Ferrari L; Stucchi R; Konstantoulea K; van de Kamp G; Kos R; Geerts WJC; van Bezouwen LS; Förster FG; Altelaar M; Hoogenraad CC; Rüdiger SGD
    Nat Commun; 2020 Jan; 11(1):571. PubMed ID: 31996674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model.
    Wang YP; Biernat J; Pickhardt M; Mandelkow E; Mandelkow EM
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10252-7. PubMed ID: 17535890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment.
    Pir GJ; Choudhary B; Kaniyappan S; Chandupatla RR; Mandelkow E; Mandelkow EM; Wang Y
    Mol Neurobiol; 2019 May; 56(5):3751-3767. PubMed ID: 30196394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tau aggregation followed by atomic force microscopy and surface plasmon resonance, and single molecule tau-tau interaction probed by atomic force spectroscopy.
    Barrantes A; Sotres J; Hernando-Pérez M; Benítez MJ; de Pablo PJ; Baró AM; Avila J; Jiménez JS
    J Alzheimers Dis; 2009; 18(1):141-51. PubMed ID: 19625749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant.
    Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
    J Neurosci; 2011 Feb; 31(7):2511-25. PubMed ID: 21325519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a DeltaK280 mutation on the unfolded state of a microtubule-binding repeat in Tau.
    Huang A; Stultz CM
    PLoS Comput Biol; 2008 Aug; 4(8):e1000155. PubMed ID: 18725924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy.
    Eckermann K; Mocanu MM; Khlistunova I; Biernat J; Nissen A; Hofmann A; Schönig K; Bujard H; Haemisch A; Mandelkow E; Zhou L; Rune G; Mandelkow EM
    J Biol Chem; 2007 Oct; 282(43):31755-65. PubMed ID: 17716969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural impact of proline-directed pseudophosphorylation at AT8, AT100, and PHF1 epitopes on 441-residue tau.
    Bibow S; Ozenne V; Biernat J; Blackledge M; Mandelkow E; Zweckstetter M
    J Am Chem Soc; 2011 Oct; 133(40):15842-5. PubMed ID: 21910444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.
    Dregni AJ; Mandala VS; Wu H; Elkins MR; Wang HK; Hung I; DeGrado WF; Hong M
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16357-16366. PubMed ID: 31358628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.
    Shimonaka S; Matsumoto SE; Elahi M; Ishiguro K; Hasegawa M; Hattori N; Motoi Y
    J Biol Chem; 2020 Oct; 295(41):13996-14014. PubMed ID: 32759167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.
    Ramachandran G; Udgaonkar JB
    J Biol Chem; 2011 Nov; 286(45):38948-59. PubMed ID: 21931162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.